chr19-7645324-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006949.4(STXBP2):​c.1356+18A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.391 in 1,563,216 control chromosomes in the GnomAD database, including 124,415 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 15738 hom., cov: 34)
Exomes 𝑓: 0.39 ( 108677 hom. )

Consequence

STXBP2
NM_006949.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.379

Publications

14 publications found
Variant links:
Genes affected
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]
STXBP2 Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 5
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microvillus inclusion disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 19-7645324-A-G is Benign according to our data. Variant chr19-7645324-A-G is described in ClinVar as Benign. ClinVar VariationId is 260088.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.683 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STXBP2NM_006949.4 linkc.1356+18A>G intron_variant Intron 15 of 18 ENST00000221283.10 NP_008880.2 Q15833-1Q53GF4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STXBP2ENST00000221283.10 linkc.1356+18A>G intron_variant Intron 15 of 18 1 NM_006949.4 ENSP00000221283.4 Q15833-1
ENSG00000268400ENST00000698368.1 linkn.*1459+18A>G intron_variant Intron 17 of 19 ENSP00000513686.1 A0A8V8TM65

Frequencies

GnomAD3 genomes
AF:
0.445
AC:
67619
AN:
152006
Hom.:
15704
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.538
Gnomad AMI
AF:
0.209
Gnomad AMR
AF:
0.470
Gnomad ASJ
AF:
0.311
Gnomad EAS
AF:
0.703
Gnomad SAS
AF:
0.362
Gnomad FIN
AF:
0.526
Gnomad MID
AF:
0.345
Gnomad NFE
AF:
0.367
Gnomad OTH
AF:
0.426
GnomAD2 exomes
AF:
0.423
AC:
74270
AN:
175436
AF XY:
0.415
show subpopulations
Gnomad AFR exome
AF:
0.545
Gnomad AMR exome
AF:
0.457
Gnomad ASJ exome
AF:
0.304
Gnomad EAS exome
AF:
0.678
Gnomad FIN exome
AF:
0.511
Gnomad NFE exome
AF:
0.368
Gnomad OTH exome
AF:
0.400
GnomAD4 exome
AF:
0.386
AC:
544019
AN:
1411092
Hom.:
108677
Cov.:
32
AF XY:
0.384
AC XY:
267644
AN XY:
697502
show subpopulations
African (AFR)
AF:
0.548
AC:
17653
AN:
32186
American (AMR)
AF:
0.459
AC:
17345
AN:
37800
Ashkenazi Jewish (ASJ)
AF:
0.307
AC:
7785
AN:
25360
East Asian (EAS)
AF:
0.722
AC:
26712
AN:
37010
South Asian (SAS)
AF:
0.343
AC:
27621
AN:
80558
European-Finnish (FIN)
AF:
0.503
AC:
25085
AN:
49918
Middle Eastern (MID)
AF:
0.333
AC:
1731
AN:
5196
European-Non Finnish (NFE)
AF:
0.366
AC:
396711
AN:
1084702
Other (OTH)
AF:
0.401
AC:
23376
AN:
58362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
17298
34595
51893
69190
86488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12856
25712
38568
51424
64280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.445
AC:
67710
AN:
152124
Hom.:
15738
Cov.:
34
AF XY:
0.451
AC XY:
33564
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.538
AC:
22345
AN:
41518
American (AMR)
AF:
0.470
AC:
7182
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.311
AC:
1079
AN:
3470
East Asian (EAS)
AF:
0.703
AC:
3632
AN:
5170
South Asian (SAS)
AF:
0.362
AC:
1744
AN:
4820
European-Finnish (FIN)
AF:
0.526
AC:
5575
AN:
10592
Middle Eastern (MID)
AF:
0.357
AC:
105
AN:
294
European-Non Finnish (NFE)
AF:
0.367
AC:
24949
AN:
67950
Other (OTH)
AF:
0.430
AC:
909
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1953
3906
5860
7813
9766
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
624
1248
1872
2496
3120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.394
Hom.:
2302
Bravo
AF:
0.447
Asia WGS
AF:
0.533
AC:
1851
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 70% of patients studied by a panel of primary immunodeficiencies. Number of patients: 67. Only high quality variants are reported. -

Mar 08, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial hemophagocytic lymphohistiocytosis 5 Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.60
DANN
Benign
0.21
PhyloP100
-0.38
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs889187; hg19: chr19-7710210; COSMIC: COSV55405675; COSMIC: COSV55405675; API